SOURCE-LINKED INTELLIGENCE
Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology
path forward to development of personalized treatment opportunities for groups of rare disease patients in a cost- and time-efficient manner. Drug repurposing, organoids, innovative clinical trials, artificial intelligence, patient registries, patient access, FAIR data
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 8826970
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T01:21:06.728Z. This is not the publication date.